Abstract:Infectious diseases present tremendous challenges to human progress and public health. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated coronavirus disease 2019 (COVID-19) pandemic continue to pose an imminent threat to humanity. These infectious diseases highlight the importance of developing innovative strategies to study disease pathogenesis and protect human health. Although conventional in vitro cell culture and animal models are useful in facilitating the development of effective therapeutics for infectious diseases, models that can accurately reflect human physiology and human-relevant responses to pathogens are still lacking. Microfluidic organs-on-a-chip (organ chips) are engineered microfluidic cell culture devices lined with living cells, which can resemble organ-level physiology with high fidelity by rebuilding tissue–tissue interfaces, mechanical cues, fluidic flow, and the biochemical cellular microenvironment. They present a unique opportunity to bridge the gap between in vitro experimental models and in vivo human pathophysiology and are thus a promising platform for disease studies and drug testing. In this Account, we first introduce how recent progress in organ chips has enabled the recreation of complex pathophysiological features of human infections in vitro. Next, we describe the progress made by our group in adopting organ chips and other microphysiological systems for the study of infectious diseases, including SARS-CoV-2 viral infections and intrauterine bacterial infections. Respiratory symptoms dominate the clinical manifestations of many COVID-19 patients, even involving the systemic injury of many distinct organs, such as the lung, the gastrointestinal tract, and so forth. We thus particularly highlight our recent efforts to explore how lung-on-a-chip and intestine-on-a-chip might be useful in addressing the ongoing viral pandemic of COVID-19 caused by SARS-CoV-2. These organ chips offer a potential platform for studying virus–host interactions and human–relevant responses as well as accelerating the development of effective therapeutics against COVID-19. Finally, we discuss opportunities and challenges in the development of next-generation organ chips, which are urgently needed for developing effective and affordable therapies to combat infectious diseases. We hope that this Account will promote awareness about in vitro organ microphysiological systems for modeling infections and stimulate joint efforts across multiple disciplines to understand emerging and re-emerging pandemic diseases and rapidly identify innovative interventions.This article has not yet been cited by other publications.

Advances in Virus-Host Interaction Research Based on Microfluidic Platforms

A Microfluidic Cell Chip for Virus Isolation Via Rapid Screening for Permissive Cells

Advancements in organs-on-chips technology for viral disease and anti-viral research

The development of droplet-based microfluidic virus detection technology for human infectious diseases.

Single-Cell Virology: On-Chip Investigation of Viral Infection Dynamics.

Recent advances in droplet microfluidics for microbiology

Physicochemical tools for studying virus interactions with targeted cell membranes in a molecular and spatiotemporally resolved context

Application of microfluidic technologies on COVID-19 diagnosis and drug discovery

A Microfluidic Platform for Real-Time and in Situ Monitoring of Virus Infection Process

Microfluidic Organs-on-a-Chip for Modeling Human Infectious Diseases

Infectomics Screening for Novel Antiviral Drug Targets

Application of Advanced Bioimaging Technologies in Viral Infections

Microfluidic Device-Based Virus Detection and Quantification in Future Diagnostic Research: Lessons from the COVID-19 Pandemic

Next-Generation Sequencing: a new avenue to understand viral RNA-protein interactions

Advances in Microfluidics Applied to Single Cell Operation

Single-Cell Virology: On-Chip, Quantitative Characterization of the Dynamics of Virus Spread from One Single Cell to Another

Virus-mimicking Nanosystems: from Design to Biomedical Applications

Advancing Microfluidic Immunity Testing Systems: New Trends for Microbial Pathogen Detection

Focus on Cell Biology of Virus-Plant and Virus-Vector Interactions.

Microfluidic Platforms for Microbial